The number of investments in this area has increased by 800% over the past year. Partly due to the pandemic, these methods have helped in the development of vaccines in a number of cases. Again, this is about data analysis, and this topic has been developing exponentially for a long time. More and more startups are appearing, for example, our startup "Syntelly
The development of drugs is a very expensive process, and reducing the timeframe even by a month is a worthy period. Anything that can reduce risks has great demand. Another question is the study of chemical space. The combination of mathematical modeling methods with machine learning helps to find fundamentally new structures, to find new structures with potentially low toxicity and high efficiency. We all know how inconvenient it is to handle vaccines and other molecules that are unstable at high temperatures. The chemical universe is huge — 1060
compounds is an astronomical number.